Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Oscar Health Inc (NYSE: OSCR) was $21.8 for the day, down -2.98% from the previous closing price of $22.47. In other words, the price has decreased by -$2.98 from its previous closing price. On the day, 20.04 million shares were traded. OSCR stock price reached its highest trading level at $22.8799 during the session, while it also had its lowest trading level at $21.35.
Ratios:
Our analysis of OSCR’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.26.
On July 15, 2025, UBS Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $11.
Piper Sandler Downgraded its Overweight to Neutral on July 14, 2025, while the target price for the stock was maintained at $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 22 ’25 when Schlosser Mario sold 395,000 shares for $18.43 per share. The transaction valued at 7,279,850 led to the insider holds 501,148 shares of the business.
MARIO T SCHLOSSER bought 395,000 shares of OSCR for $7,280,996 on Sep 22 ’25. On Jun 20 ’25, another insider, RANMALI BOPITIYA, who serves as the Officer of the company, bought 30,000 shares for $18.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 5809802752 and an Enterprise Value of 2452815360. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.53 while its Price-to-Book (P/B) ratio in mrq is 4.86. Its current Enterprise Value per Revenue stands at 0.229 whereas that against EBITDA is -24.768.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.88, which has changed by 0.25720882 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.80, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is 24.68%, while the 200-Day Moving Average is calculated to be 40.50%.
Shares Statistics:
OSCR traded an average of 24.18M shares per day over the past three months and 19249820 shares per day over the past ten days. A total of 222.91M shares are outstanding, with a floating share count of 189.35M. Insiders hold about 26.77% of the company’s shares, while institutions hold 55.65% stake in the company. Shares short for OSCR as of 1757894400 were 34579578 with a Short Ratio of 1.43, compared to 1755216000 on 57679570. Therefore, it implies a Short% of Shares Outstanding of 34579578 and a Short% of Float of 17.24.
Earnings Estimates
. The current market rating for Oscar Health Inc (OSCR) reflects the collective analysis of 7.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.97, with high estimates of -$0.84 and low estimates of -$1.18.
Analysts are recommending an EPS of between -$1.08 and -$1.91 for the fiscal current year, implying an average EPS of -$1.39. EPS for the following year is -$0.32, with 7.0 analysts recommending between $0.16 and -$1.06.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 7 analysts. It ranges from a high estimate of $3.13B to a low estimate of $3.05B. As of. The current estimate, Oscar Health Inc’s year-ago sales were $2.42BFor the next quarter, 7 analysts are estimating revenue of $3.06B. There is a high estimate of $3.09B for the next quarter, whereas the lowest estimate is $3.03B.
A total of 7 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.11B, while the lowest revenue estimate was $11.99B, resulting in an average revenue estimate of $12.06B. In the same quarter a year ago, actual revenue was $9.18BBased on 7 analysts’ estimates, the company’s revenue will be $11.31B in the next fiscal year. The high estimate is $12.13B and the low estimate is $10.9B.
